2^nd Worldwide Forum on Alzheimer and Dementia June 21-22, 2022 New York, USA

Session1: Dementia
Dementia is a collective general term for memory loss and other cognitive declines, such as forgetfulness. It is a symptom of several underlying brain disorders and diseases. Alzheimer’s disease is the most common cause of dementia, a continuous decline in behavioural, thinking, and social skills. The signs and symptoms include memory problems, communication difficulties, changes in mood and behaviour, difficulties with organizing and planning one’s day-to-day life, and the gradual loss of control of physical functions. They face many problems in the society in physical, mental and social pressure. The seven stages of syndrome are: No impairment, Very mild cognitive decline, Moderate cognitive decline, Mild cognitive decline.

Session 2: Alzheimer’s Disease

Alzheimer’s disease is the most common cause of dementia — a continuous decline in thinking, behavioural and social skills that disrupts a person’s ability to function independently. The early signs of the disease may be forgetting recent events or conversations. As the disease progresses, a person with Alzheimer’s disease will develop severe memory impairment and lose the ability to carry out everyday tasks. Current Alzheimer’s disease medications may temporarily improve symptoms or slow the rate of decline. These treatments can sometimes help people with Alzheimer’s disease maximize function and maintain independence for a time. In this session we are able to discuss on medical specialty changes in Brain, Amyloid super molecule, Genetic associations.

Session 3: Neurology & Neurosurgery

Neurosurgery or neurological careful treatment is the therapeutic strong point focused on the aversion, examination, and recovery of issues which influence any piece of the on edge gadget alongside brain, spinal twine, fringe nerves, and additional cranial cerebrovascular gadget. They aid the visualization of intra cerebral drain.This leads to the loss of memory functions like Dementia and Alzheimer. Neurology accompanied with the central nervous system and peripheral nervous system. Peripheral nervous system contains all nerves outside of the nervous system. The departments comes under neurology are; Neuro genetics, Neuropharmacology, Neuro immunology, Neuro paediatric, Neuro psychiatry.

Session 4: Psychiatry and Mental Health

Psychiatry is the field of medicine focused on diagnosing, treating, and preventing behavioral, emotional, and mental disorders. Psychiatric or mental disorders are symptoms characterized by clinically significant disturbance in an individual’s cognition, behavior, or emotion that reflects a dysfunction within the psychological processes underlying mental function. Psychiatry and psychotherapy, mental health & anxiety disorders, mental health care for LGBT older adults, neuropsychiatry and behavioural neurology.

Session 5: Ageing and Depression

Aging is just a part of the life cycle. A person is born, goes through childhood, adolescence, and adulthood, and begins to age at a certain point in time. Occasional lapses in memory that disrupt daily life are not typical of aging; they may be a symptom of dementia. Depression is a common mental disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life, feelings of guilt or low self-worth, decreased energy, disturbed sleep or appetite, and poor concentration. Hypertension, age discrimination, hypertension and aging-related cardiac and vascular dysfunctions, grontology.

Session 6: Neurodegenerative Diseases

Neurodegenerative disease is the progressive degeneration of the central nervous system and peripheral nervous system. This progressive degeneration collapses the function and structure of the brain. The common neurodegenerative diseases are Alzheimer’s diseases, Parkinson’s diseases. Neurodegenerative diseases are incurable conditions that result in progressive degeneration of nerve cells. Spinal muscular atrophy is a type of neurodegenerative diseases. In this case the treatment can to prolong the life, it cannot be cured. The symptoms of multiple sclerosis are vision loss, fatigue, pain and impaired coordination; Amyotrophic lateral sclerosis, aneurysm, multiple sclerosis, spinal cord injury

Session 7 : Parkinson's Diseases 

Parkinson's Diseases (PD) is a never-ending and dynamic neurological problem that influences engine work, inflicting bradykinesia, postural unsteadiness, inflexibility and tremor very still. Side effects develop progressively, making start finding troublesome. Parkinson's symptoms commonly begin gradually and get worse over time. As the disease increases, people may have difficulty in walking and talking. The problems are common in people with dementia with Lewy Bodies (LBD) and are often present at the time of diagnosis. Parkinson's disease appears when nerve cells, or neurons, in an area of the brain that controls movement become defective or die.Other symptoms may include; Depression, other emotional changes, difficulty swallowing,chewing, and speaking.

Session 8: Autoimmune Disorders

A healthy immune system defends the body against disease and infection. But if the immune system malfunctions, it mistakenly attacks healthy cells, tissues, and organs. Called autoimmune disease, these attacks can affect any part of the body, weakening bodily function and even turning life-threatening. An autoimmune disorder may result in: The destruction of body tissue, abnormal growth of an organ, changes in organ function. An autoimmune disorder may affect one or more organ or tissue types. Areas often affected by autoimmune disorders include: Blood vessels, connective tissues, endocrine glands such as the thyroid or pancreas, joints, muscles, red blood cells, skin.

Neurology focuses on a broad array of disorders and cures of the brain and connecting neurons in line with the newest survey. Conducted by UN agency, it's disclosed that neurologic Disorders Encompassing Stroke, alzheimer & dementedness, brain disorder and many more accounts for over twelve-tone music of deaths worldwide on an average. It’s conjointly expected that the quantity of incapacity–adjusted life years non-existent because of neurological disorders area unit expected to accelerate from ninety-five million globally in 2015 to 103million by 2030. Headache Cases (about 1500 million) Migraine (about 1000 million) Medication overuse headaches (about 60 million) alzheimer's disease and dementedness (about 46 million) Between 1990 and 2020, the number of deaths from neurological disorders magnified by 36.7%   and also the variety of DALYs by 7.4%. The rates of cases per one hundred, 000 people increased in shaking palsy (by fifteen.7%), Alzheimer's disease (2.4%), motor nerve fiber malady (3.1%), and brain and nervous system cancers (8.9%).  Higher rates of prevalence of neurological disorders in rural areas, 6-8 million folks with epilepsy, and high case fatality rates of stroke (27-42%) demand urgent methods in the Asian country  The global neurobiology market was valued at around USD 26,350 million within the year 2016. It’s expected to succeed in approximately USD 34,800 million by 2024. The global Neuroscience market is anticipated to exhibit a CAGR of a lot of than 3.5% between 2017 and 2024.

Importance and Scope

According to WHO, psychiatry is defined as a state of well-being in which every individual realizes his or her own potential and can cope with the normal stresses of life, work productively and fruitfully, and are able to contribute to his or her community. psychological Syndrome is the health condition that is characterized by alterations in thinking, mood, and behavior that is associated with distress or impaired functioning. Mental disorders contribute to problems that may include disability, pain, or death. Globally, depression affects about 400 million, dementia affects about 35 million, while schizophrenia which affects about 21 million people. Unipolar (also known as Major) depressive disorder is the third leading cause of disability worldwide, of any condition mental or physical, accounting for 65.5 million years lost. Overall list, responsible for 23.7 million DALYs globally, while other drug-use disorders accounted for 8.4 million. Schizophrenia causes a total loss of 16.8 million DALY, and bipolar disorder 14.4 million. Panic disorder leads to 7 million years lost, obsessive-compulsive disorder 5.1, primary insomnia 3.6, and post-traumatic stress disorder 3.5 million daily. Over one’s entire lifetime, the average American has a 47.4 percent chance of having any kind of mental health disorder. It has been reported that, in Germany, depression is ten times more frequent.

15th International Conference on Dementia and Alzheimer’s disease -2019

Conference Series LLC Ltd successfully hosted “15th International Conference on Dementia and Alzheimer’s Disease” scheduled during March 25-26, 2019 at Osaka, Japan. The principle subject of our meeting is “New and Emerging Target Therapies in Dementia Care and Alzheimer’s disease” This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Neuroscience. The extremely illustrious conference hosted by Conference series LLC was marked with the attendance of young and brilliant researchers, clinicians, business delegates and talented student communities. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

11th International conference on Vascular Dementia -2018

The 11th International conference on Vascular Dementia hosted by Conference Series llc Ltd took place at Moscow, Russia during July 23-25, 2018. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series llc LTD Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world have made the conference one of the most successful and productive events in 2019 from Conference Series llc Ltd. The conference was marked by the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought-provoking keynote and plenary presentations highlighting the theme “Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health”

11th International Conference on Alzheimer’s disease and Dementia -2018

We would like to thank all of our wonderful keynotes, speakers, conference attendees, students, associations, media partners, and guests for making Dementia 2018 a successful event. With the overwhelming success of the previous conferences, Conference series hosted the 11th International Conference on Alzheimer’s disease and Dementia on May 24-25, 2018 at Vienna, Austria. Euro Dementia 2018 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Neuroscience. The extremely illustrious conference hosted by Conference series LLC was marked with the attendance of young and brilliant researchers, clinicians, business delegates and talented student communities. The conference was organized around the theme “Future of Dementia & Alzheimer: Innovations and Research Outlook”. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

9th International Conference on Alzheimer’s Disease & Dementia -2017

9th International Conference on Alzheimer’s Disease & Dementia was organized during October 16-18, 2017 at Holiday Inn Aurelia, Rome, Italy with the support and contribution of the Organizing Committee Members. Firstly we must thank you for trusting us and participating at Dementia 2017, a global platform to discuss various important aspects of Alzheimer’s disease, Dementia and Neurological disorders. There are infinite reasons to extend our gratitude to you for making Dementia 2017 an outstanding conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Dementia 2017 a new heights in the field of Neuroscience. The conference was marked with the attendance of young and brilliant researchers, business delegates, exhibitors and talented student communities representing more than 15 countries, who have driven this event into the path of success.

5th International Conference on Alzheimer’s Disease & Dementia -2016

5th International Conference on Alzheimer’s Disease & Dementia was organized during September 29-October 01, 2016 at Hilton London Heathrow Airport, London, UK with the support and contribution of the Organizing Committee Members. All the participants were awarded with 5.25 AMA PRA Category 1 Credits. Firstly we must thank you for trusting us and participating at Dementia 2016, a global platform to discuss various important aspects of Alzheimer’s disease, Dementia and Neurological disorders. There are infinite reasons to extend our gratitude to you for making Dementia 2016 an outstanding conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Dementia 2016 a new heights in the field of Neuroscience. The conference was marked with the attendance of young and brilliant researchers, business delegates, exhibitors and talented student communities representing more than 15 countries, who have driven this event into the path of success.

With the valuable feedback received from the participants of Dementia congress 2020, Conference Series will be glad to announce its next event i.e. Worldwide Forum on Alzheimer and Dementia scheduled for October 25-26, 2021 at Rome, Italy